Ann: Investor Presentation, page-40

With peer-review and other pre-publishing prerequisites, alas expecting formal academic publication on these ATI results (or any results) in less than six months post is optimistic.

You will be well aware of course Kain, but it appears to need saying from other posts that appear to underestimate the time biotech pathways take. The more exposure like this the higher the likelihood/quality of publication.

For those who don't know, Dr Jay Ebert, in Kain's medical congress post above, is a director of the Australian 'Orthopedic Research Foundation' and a long-term professional exponent of ATI (and ACI) and a 'fellow' in Orthopedics i.e. he knows his stuff and has been recognised for knowing his stuff. Thanks for the post Kain, this medical conference stuff hard to find.